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Introduction
Over the last 10 years, seven new anti-epileptic drugs (AEDs) have become available in Ireland. These newer agents have a number of advantages over older AEDs. 1 Many have longer half lives, enabling once or twice daily dosing. They have a reduced potential for drug interactions, and although most of them undergo extensive hepatic *Corresponding address. Tel.: +353-1-8092270. E-mail address: normandelanty@eircom.net (N. Delanty).
metabolism (with the exception of levetiracetam, gabapentin and vigabatrin), they are less likely to cause hepatic enzyme induction, facilitating their use as add-on agents and making polypharmacy safer. 2, 3 Data from animal models and clinical trials suggest that they have a safety profile which is superior to the older AEDs.
There are estimated to be up to 40,000 people with epilepsy in Ireland, affecting 1 in 200 adults and 1 in 100 children. This is comparable to the prevalence figures world-wide, estimated at 5-10 per 1000. 4 Epilepsy carries with it a mortality rate which is two to three times that of the general population. 5, 6 While this excess is made up partly by seizure-related accidental deaths 7 (trauma, drowning), sudden unexpected deaths in epilepsy 8 (SUDEP) and death from underlying diseases (e.g. strokes, infections of the central nervous system), a recognised contribution comes from drug intoxication. [9] [10] [11] Gowers in 1901 was the first to recognise and document a specific association between epilepsy and suicide. 12 The association between epilepsy and psychiatric co-morbidity is well recognised. AEDs are relatively common agents taken in intentional drug overdose. 13 Hawton et al. 14 looked at the association between suicide and epilepsy over a 2-year period (1976) (1977) . Eighty-four percent of suicide attempts among patients with epilepsy in this study involved self-poisoning, and in 65% of these cases, AEDs were consumed. A 6-year retrospective study by Manon-Espaillat et al. 15 found that suicide occurred in 18% of reported drug intoxications with AEDs between 1979 and 1985. The incidence of suicide in patients with epilepsy as a percentage of deaths in the same population was averaged over 17 studies at 13.2%. More recent figures suggest an incidence of 5-7% 16 and male patients with epilepsy are a particularly vulnerable group. 17 The prevalence of depression has been reported as 60% in certain epilepsy populations. 18, 19 Mendez et al. 20 reviewed the possible causative factors for deliberate self-poisoning in epilepsy. Across the cohort of patients who were hospitalised for suicide attempts by drug overdose, when matched by age, sex and race, patients with epilepsy had more borderline personality disorders with multiple impulsive suicide attempts and psychosis compared with patients without epilepsy. 21 Patients with complex partial seizures were especially felt to be at high risk from attempted suicide. A case control study evaluating a large cohort of patients in Sweden, found a high incidence of psychiatric disease amongst the patients with epilepsy who attempted suicide, with depression being the most common diagnosis. 22, 23 In excess of 81% of this group carried a diagnosis of intercurrent psychiatric disease. Hence, the safety of anti-convulsants has significant implications for the management and prevention of mortality in situations of non-accidental overdose.
In acute toxicity studies with gabapentin in mice and rats, at maximum doses of 2000-8000 mg/kg, ataxia and laboured breathing were reported but no deaths. With gabapentin, at doses exceeding 600 mg, saturation of the carrier-mediated absorption pathway results in reduced bioavailability with increasing doses. 24 The mean lethal doses of lamotrigine in mice and rats have been established. 25 Acute median oral lethal doses for mice were 202-245 and 163-205 mg/kg for rats. Animal studies with levetiracetam demonstrated selective protection against induced seizures with a very high safety margin for the drug in rodents. 26 With oxcarbazepine, there is a low level of hepatic induction of cytochrome P450 microsomal system. 27 In acute toxicity studies across multiple species, extremely high doses of oral oxcarbazepine were tolerated and there were no compound-related deaths. Animal studies with topiramate demonstrated, there was no accumulation of the drug at higher doses and there was no autoinduction or inhibition of enzymes that metabolise topiramate. 28 The clinical development of vigabatrin was delayed by the finding of microvacuolation in the white matter of rodents and dogs. 29 Since then however, extensive studies have confirmed that microvacuolation is species specific and does not occur in humans.
Methods
We undertook a study to examine the frequency and outcome of non-accidental overdose with seven newer AEDs in an Irish population during the 5-year period 1996-2000. A study of this nature has not been undertaken in Ireland previously. This retrospective study was performed in the Department of Neurology, Beaumont Hospital in collaboration with the National Poisons Information Centre (NPIC), Beaumont Hospital.
We reviewed data provided by the NPIC and the Central Statistics Office (CSO). The NPIC are contacted by hospitals all around the country when patients present to Accident and Emergency (A&E) departments with deliberate self-poisoning. The type of agent(s) and severity of the overdose reported is noted by the NPIC and any potentially fatal overdoses are followed up by the NPIC through telephone contact with the relevant medical team in Beaumont Hospital. The CSO keep a register of all reported deaths due to AEDs. Deaths from anti-convulsant agents other than phenytoin and succinimides are represented within a single category by the CSO, therefore it is not possible to distinguish mortalities from data between individual AEDs.
In addition, we undertook an extensive literature review of established case reports of overdose with the newer AEDs and the published literature reviewing the general safety profile of these drugs. We were assisted by medical information from the pharmaceutical industry retrieved from their databases, specifically addressing the safety profile of these agents in situations of overdose. The pharmaceutical industry had comprehensive data for any potential fatalities from poisoning with the newer AEDs from 1996 to 2000.
A comparative review was undertaken with the older agents for the same time period.
Results
The total number of reported overdoses using any of the seven newer AEDs over the 5-year period 1996-2000 inclusive was 164. In addition there were three reports from the United Kingdom and seven others requesting information.
The majority of overdoses involved more than one agent (115 of 164 cases). There were no reported mortalities among the cases reported from 1996 to 2000 (see Table 1 ). It was possible to confirm this through follow up information from both the NPIC and the pharmaceutical industry data.
From 1996 to 2000, eight of the cases of deliberate self-poisoning recorded above were admit- 
Case 1
An 18-year-old girl, with a background of epilepsy, presented to the A&E department with convulsions. Through collateral history, it was discovered that she has ingested 45 tablets of lamotrigine and 20 tablets of penicillin in the previous 2 h. The precise doses ingested are not known. She was treated with activated charcoal and underwent cardiac monitoring. She recovered on supportive therapy without complication.
Case 2
A 21-year-old man presented to the A&E department with drowsiness having taken an overdose of his medications which consisted of sodium valproate, carbamazepine, thioridazine and gabapentin. It was uncertain how many tablets he ingested in total. He was too drowsy for gastric lavage or charcoal administration. He was monitored closely and treated symptomatically and subsequently made a complete recovery.
Case 3
A 22-year-old woman with a background history of epilepsy, presented to the A&E department, admitting to consuming unknown quantities of vigabatrin and carbamazepine. She was asymptomatic at presentation and was treated with activated charcoal. She remained asymptomatic and was discharged after overnight observation and psychiatric review.
Discussion
From review of published literature and medical information provided from the pharmaceutical industry database, deliberate overdoses with the seven newer agents are infrequent (see Table 2 ). Acute life-threatening toxicity has not been observed to date with gabapentin. Reduced absorption of the drug at higher doses may limit drug bioavailability at the time of overdosing, therefore reducing toxicity. Overdose with up to 49 g of gabapentin has resulted in no serious consequences. 24 With lamotrigine, numerous case reports show recovery without serious sequel for doses up to 4.5 g. [30] [31] [32] However, fatalities have been reported in cases of lamotrigine poisoning. In a post-mortem case, where the distribution of lamotrigine was determined, the blood concentration of lamotrigine was 52 mg/l (therapeutic range of up to 14 mg/l) with no other AEDs detected. The precise cause of death in this case was undetermined. 33 Both gabapentin and lamotrigine confer an additional advantage in prescribing that they have both been reported to have mood stabilising effects in patients.
There have been no case reports relating to acute intoxication with either levetiracetam or oxcarbazepine to date. There have been unpublished reports of overdoses with topiramate, with overdoses of up to 100 g of topiramate, without any resulting fatality. A study reviewing 23 cases of overdose with tiagabine reported complete recovery in all patients. 34, 35 There have been no case reports relating to acute intoxication with either levetiracetam or oxcarbazepine and no reported fatalities with vigabatrin in the published literature to date.
In our study, we found that despite the number of patients who took overdoses of the newer AEDs, whether in isolation or in combination with other drugs, there were no fatalities seen amongst the 164 reported cases. The only other comparable population study in the literature was a Polish study, which was conducted between 1990 and 1992 by Miller et al., looking at suicide attempts reported through their Poisons Control Centre. 36 In the above study, 9% of all patients treated for attempted suicide carried a diagnosis of epilepsy. The number of cases of non-accidental overdose with the older anti-convulsants reported to the NPIC between 1996 and 2000 is represented in Table 3 . The outcome of cases that were admitted solely to Beaumont Hospital is represented in Table 4 . There were no fatalities amongst the 26 cases admitted. Five of these admissions, however were prolonged hospital admissions lasting a minimum of 1 week, signifying more serious consequences from drug toxicity.
There were 320 cases of poisoning with older AEDs reported to the NPIC. The number of fatalities outside admissions to Beaumont Hospital cannot be determined for the same time period. There are, however, numerous case reports citing non-accidental overdoses and case reports of fatalities with most of the older AEDs. [37] [38] [39] Acute, life threatening fatalities have been reported with phenobarbitone, 37 sodium valproate, 38 phenytoin 39 and carbamazepine. 40 This contrasts with the paucity of fatalities from the newer AEDs.
Given the high incidence of impulsive suicidal gestures reported among patients with epilepsy, especially partial epilepsy, as well as the high prevalence of depression, the newer generation AEDs may confer an additional advantage in prescribing. The absence of serious consequences from deliberate self-poisoning of these agents in our study is supportive evidence for their superior safety profile in normal prescribing but also in the management and prevention of fatality from the significant risk of non-accidental overdose of AEDs in individuals with epilepsy.
